Zacks Investment Research upgraded shares of RADNET INC (RDNT) from UNDERPERFORM to NEUTRAL on May 14, 2013, with a target price of $2.50.
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on RADNET INC (RDNT),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment